In vivo toxicity and pharmacokinetic features of B43(Anti-CD19)-Genistein immunoconjugate.
Leuk Lymphoma. 1998 Jul;30(3-4):389-94. doi: 10.3109/10428199809057550.
Leuk Lymphoma. 1998.
PMID: 9713969